PBM company Rightway eyes IPO after new funding. Ike Swetlitz, Bloomberg September 24, 2026 10:38 AM CDT Rightway, an upstart pharmacy benefit manager covering about 3 million people, is considering an initial public offering in the years ahead as it tries to chip away at a market long dominated by some of the largest healthcare conglomerates in the U.S. Enjoy complimentary access to this article, newsletters and more. The venture will initially focus on cancer care.

Rightway raises $155M to expand ai-powered pharmacy platform. 24 September 2026 Key Takeaways * Rightway has raised $155 million in Series E funding led by Francisco Partners. * Rightway will use the funding to expand its AI and pharmacy technology capabilities. * The company serves 45 Fortune 500 companies with pharmacy and care navigation solutions. Rightway raises $155M Series E funding. Rightway has raised $155 million in Series E financing led by Francisco Partners. Existing investors Thrive Capital and Khosla Ventures also participated. The funding will support Rightway's next phase of growth. The company provides pharmacy benefit management and care navigation services to employers. Rightway now serves 45 Fortune 500 companies. Its platform combines pharmacy expertise, care navigation, technology, and aligned financial incentives. The company is targeting rising prescription drug costs. It aims to help employers manage spending while improving healthcare experiences for members. Prescription drug spending increased 9.4% among large US employers in 2025. Overall health benefit costs increased by 6% during the same period. Prescription drugs are also projected to become the fastest-growing major healthcare spending category. SureSpend targets rising pharmacy costs. Rightway has built its financial model around greater transparency. Its approach removes incentives to profit from higher pharmacy spending. The company backs this model with its SureSpend platform. The system includes a Precision Pricing Guarantee that sets a maximum on pharmacy spending. Its Zero-Markup Wrap covers categories commonly excluded from pharmacy spending guarantees. These include GLP-1 medications and rare high-cost drugs. Rightway provides these categories at true net cost. It also passes 100% of rebates through to employers. The financial model works alongside clinical support. Pharmacists guide members towards appropriate medications and lower-cost treatment options. Rightway says this approach addresses costs across the pharmacy supply chain. It also helps members make better decisions about their healthcare benefits. AI expands Rightway's clinical workflows. Rightway combines AI-powered healthcare technology with pharmacist expertise to simplify medication decisions, improve care navigation, and provide more personalised support. Source: Created by Ventureburn The company also plans to improve the technology supporting its pharmacy benefits model. AI will support clinical workflows and member navigation. Pharmacists will remain involved in helping members understand medications and treatment choices. Rightway Chief Pharmacy Officer Kristin Devlin said the model gives pharmacists more time for clinical work. Pharmacists can focus on helping members find appropriate treatments and manage medication concerns. The company also provides broader care navigation services. Members can receive support when finding quality care and using healthcare benefits. Rightway said its technology can reduce administrative costs across the healthcare ecosystem. It also aims to simplify healthcare decisions for members and plan sponsors. The company combines automated technology with human clinical expertise. This model is designed to deliver savings without removing personalised member support. Rightway's platform also connects pharmacy and broader healthcare navigation. Francisco Partners backs Rightway's growth. Francisco Partners said employers are demanding greater accountability from healthcare partners. The investment firm also highlighted rising demand for transparency and value. Ezra Perlman, Co-President at Francisco Partners, highlighted Rightway's technology and clinical expertise. He said the model could support further growth among large employers. Rightway was built around pharmacy navigation and member support. Its platform now reaches a significant portion of large US employers. The company says nearly 10% of Fortune 500 companies have shifted their pharmacy benefits to its model. Its current client base includes 45 Fortune 500 companies. The new financing comes as employers face continued healthcare cost pressures. Rightway plans to deepen its employer reach while expanding its technology. The company will also strengthen its AI-powered infrastructure. Its broader goal is to make pharmacy spending more predictable and transparent. The funding provides additional capital for that expansion. It also supports Rightway's strategy of combining pharmacy management with care navigation. To stay updated on crypto venture capital funding and market trends, visit its venture capital news section for more insights. Clinton Nwachukwu is a crypto and finance writer with an MBA in Artificial Intelligence and 6+ years of experience creating content for leading global brands. He turns complex topics into clear, actionable insights for readers worldwide. Disclaimer VentureBurn is a media platform covering the latest in cryptocurrency, artificial intelligence, venture capital, and the startup ecosystem. Opinions expressed on VentureBurn are for informational purposes only and do not constitute investment advice. Before making any high-risk investments in digital assets or emerging technologies, readers should conduct their own due diligence. All transactions and financial decisions are made at your own risk, and any losses incurred are solely your responsibility. VentureBurn does not endorse or recommend the buying or selling of any digital assets and is not a licensed investment advisor. Please note that VentureBurn may participate in affiliate marketing programs.